Clinical News: Page 1278

Chemo, radiation, and stem cell transplantation effective for brain lymphoma

By Reuters Health

NEW YORK (Reuters Health), Sep 1 - A sequential protocol of chemotherapy, autologous stem cell transplantation, and hyperfractionated whole brain radiation therapy is highly effective as first-line treatment of primary central nervous system lymphoma (PCNSL), German researchers report in the Journal of Clinical Oncology.

August 31, 2006

Elekta inks US Oncology deal

By AuntMinnieEurope.com staff writers

Swedish radiation therapy firm Elekta said it has signed an agreement with radiation therapy center operator US Oncology of Houston outlining pricing as well as terms and conditions for Elekta's technology for intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT).

August 30, 2006

Early bisphosphonate treatment benefits infants with osteogenesis imperfecta

By Reuters Health

NEW YORK (Reuters Health), Aug 31 - Early cyclical neridronate treatment has positive effects on growth and fracture rate in infants with severe osteogenesis imperfecta (OI), according to researchers. In a study published in the August issue of the Journal of Pediatrics, Italian researchers prospectively assessed the efficacy of bisphosphonate treatment in infants with severe OI.

August 30, 2006

Foam sclerotherapy safe and effective for varicose veins

By Reuters Health

NEW YORK (Reuters Health), Aug 30 - Ultrasound-guided foam sclerotherapy safely achieves complete occlusion in 91% of legs with varicose veins, according to a report in the British Journal of Surgery for August. Still, longer follow-up is needed to determine if the benefits are lasting.

August 29, 2006

Elekta acquires majority in BMEI

By AuntMinnieEurope.com staff writers

Swedish radiation therapy firm Elekta reported that it has acquired an 80% equity stake in Beijing Medical Equipment Institute (BMEI), a Chinese provider of radiation therapy equipment.

August 23, 2006

Low ankle-brachial index: atherosclerosis risk factor

By Reuters Health

NEW YORK (Reuters Health), Aug 23 - A low ankle-brachial index (ABI) is prevalent in patients with established atherothrombotic disease and is present in nearly one-third of those at risk, report investigators with the international "a Global Atherothrombosis Assessment (AGATHA)" study.

August 22, 2006

CT urography useful in diagnosing bladder cancer

By Reuters Health

NEW YORK (Reuters Health), Aug 22 - Use of CT urography to evaluate macroscopic hematuria possibly due to bladder cancer obviates the need for intravenous urogram and ultrasound and can help determine whether cystoscopy is warranted, new research suggests.

August 21, 2006

Iso-osmolar contrast medium recommended in chronic kidney disease

By Reuters Health

NEW YORK (Reuters Health), Aug 22 - Patients with chronic kidney disease (CKD), particularly those with diabetes mellitus, have a higher risk of contrast-induced nephropathy with a low-osmolar contrast medium than with isosmolar iodixanol, researchers report in the August 15 issue of the Journal of the American College of Cardiology.

August 21, 2006

U.K. hospitals could close under NHS reforms

By Reuters Health

LONDON (Reuters), Aug 18 - Hospitals across England may have to close or cut services under plans to reduce the growing National Health Service (NHS) deficit, the government said on Friday. The Department of Health said NHS bosses must look at alternatives to treating patients in hospital after the service doubled its deficit.

August 17, 2006

Proton beam therapy effective in controlling hepatic tumors

By Reuters Health

NEW YORK (Reuters Health), Aug 17 - Patients with hepatocellular carcinoma and who have few other treatment options are likely to benefit from proton beam therapy, Japanese researchers report in the August issue of Cancer.

August 16, 2006

Alendronate better than alfacalcidol for preventing steroid-induced bone loss

By Reuters Health

NEW YORK (Reuters Health), Aug 17 - In a study of patients with rheumatic diseases, alendronate was more effective than alfacalcidol at preventing glucocorticoid-induced bone loss, according to a report in the New England Journal of Medicine.

August 16, 2006

Breast cancer-involved sentinel nodes often contain micrometastases

By Reuters Health

NEW YORK (Reuters Health), Aug 15 - Twenty-three percent of breast cancer patients with an involved sentinel lymph node have a sentinel node that contains micrometastases, according to a report in the August 1st issue of Cancer. Sixteen percent of patients have a sentinel node containing submicrometastases.

August 14, 2006

Page 1278 of 1290